Federal judge declines to block Medicaid work requirements

Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns

In his latest set of sweeping tariffs on the pharmaceutical industry, President Donald Trump has announced a 200% levy on imported generic drugs by the year 2029.

HHS releases government-wide policy to prohibit gain-of-function research

The Trump Administration has released a new United States Government Policy for Stopping High-Risk Life Sciences Research, a framework that prohibits federally supported dangerous gain-of-function research while establishing stronger oversight for life sciences research that could pose significant risks to public health, biosecurity, or national security.

July 31, 2026

Vol.52 No.30

By Claire Marie Porter

Capitol Hill

Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%

The Centers for Medicare & Medicaid Services is planning a 33.4% cut to the reimbursement payments hospitals receive for all drugs acquired through the 340B program, according to a draft guidance published on July 7.

Hegseth orders testosterone testing for troops as FDA moves to loosen TRT prostate cancer warnings
Experts caution the move amounts to a “huge, unregulated, natural experiment”

In a video captioned “The High-T Department of War” and posted on X, Secretary of Defense Pete Hegseth announced that he was authorizing a screening program for troops to ensure “you have the right testosterone levels to operate at your absolute best.”

July 24, 2026

Vol.52 No.29

By Claire Marie Porter

Cancer Policy

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

HHS and the Centers for Medicare & Medicaid Services deferred more than $1 billion in federal Medicaid payments to California and Minnesota as these states submit additional documentation supporting certain Medicaid claims.

HHS joins Trump’s drive to use AI to address chronic disease

HHS has joined President Trump’s “Genesis Mission,” an artificial intelligence platform to harness federal scientific datasets. The purpose of the move is to use AI to further Robert F. Kennedy Jr.’s efforts to end what he calls “the chronic disease crisis,” a focal point of his Make America Healthy Again strategy.

July 24, 2026

Vol.52 No.29

By Claire Marie Porter

Federal judge declines to block Medicaid work requirements

YOU MAY BE INTERESTED IN

Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns

HHS releases government-wide policy to prohibit gain-of-function research

Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%

Hegseth orders testosterone testing for troops as FDA moves to loosen TRT prostate cancer warnings
Experts caution the move amounts to a “huge, unregulated, natural experiment”

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

HHS joins Trump’s drive to use AI to address chronic disease

Renew today!

Subscriber content

Never miss an issue!

Login

Federal judge declines to block Medicaid work requirements

YOU MAY BE INTERESTED IN

Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns

HHS releases government-wide policy to prohibit gain-of-function research

Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%

Hegseth orders testosterone testing for troops as FDA moves to loosen TRT prostate cancer warningsExperts caution the move amounts to a “huge, unregulated, natural experiment”

HHS defers more than $1B in Medicaid payments to California, Minnesota pending review of high-risk claims in crackdown on fraud

HHS joins Trump’s drive to use AI to address chronic disease

Never miss an issue!

Login

Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns

Hegseth orders testosterone testing for troops as FDA moves to loosen TRT prostate cancer warnings
Experts caution the move amounts to a “huge, unregulated, natural experiment”